Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Return on Assets (2020 - 2025)

Benitec Biopharma (BNTC) has disclosed Return on Assets for 6 consecutive years, with 0.17% as the latest value for Q1 2025.

  • Quarterly Return on Assets rose 102.0% to 0.17% in Q1 2025 from the year-ago period, while the trailing twelve-month figure was 0.17% through Mar 2025, up 102.0% year-over-year, with the annual reading at 0.76% for FY2024, 290.0% up from the prior year.
  • Return on Assets hit 0.17% in Q1 2025 for Benitec Biopharma, up from 0.21% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.17% in Q1 2025 to a low of 3.01% in Q2 2023.
  • Historically, Return on Assets has averaged 1.15% across 5 years, with a median of 1.09% in 2021.
  • Biggest five-year swings in Return on Assets: crashed -145bps in 2022 and later surged 237bps in 2024.
  • Year by year, Return on Assets stood at 1.09% in 2021, then decreased by -13bps to 1.23% in 2022, then grew by 27bps to 0.9% in 2023, then surged by 77bps to 0.21% in 2024, then rose by 19bps to 0.17% in 2025.
  • Business Quant data shows Return on Assets for BNTC at 0.17% in Q1 2025, 0.21% in Q4 2024, and 0.35% in Q3 2024.